CN105521036A - 降血压茶饮 - Google Patents
降血压茶饮 Download PDFInfo
- Publication number
- CN105521036A CN105521036A CN201610089076.5A CN201610089076A CN105521036A CN 105521036 A CN105521036 A CN 105521036A CN 201610089076 A CN201610089076 A CN 201610089076A CN 105521036 A CN105521036 A CN 105521036A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood pressure
- tea drink
- boil
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003276 anti-hypertensive effect Effects 0.000 title abstract 4
- 241001122767 Theaceae Species 0.000 title 1
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 18
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 230000036772 blood pressure Effects 0.000 claims description 26
- 244000305267 Quercus macrolepis Species 0.000 claims description 17
- 241000208365 Celastraceae Species 0.000 claims description 16
- 235000000336 Solanum dulcamara Nutrition 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 12
- 241000272522 Anas Species 0.000 claims description 11
- 102000002322 Egg Proteins Human genes 0.000 claims description 11
- 108010000912 Egg Proteins Proteins 0.000 claims description 11
- 210000004681 ovum Anatomy 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 9
- 238000005352 clarification Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 241000218628 Ginkgo Species 0.000 claims 3
- 244000194101 Ginkgo biloba Species 0.000 abstract description 15
- 206010020772 Hypertension Diseases 0.000 abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 10
- 244000269722 Thea sinensis Species 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 3
- 241000272525 Anas platyrhynchos Species 0.000 abstract 1
- 241001365752 Castanopsis sclerophylla Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 235000013601 eggs Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000011049 filling Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 239000003814 drug Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000007530 Essential hypertension Diseases 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- -1 calcium antagonists Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 108010072661 Angiotensin Amide Proteins 0.000 description 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 244000036905 Benincasa cerifera Species 0.000 description 1
- 235000011274 Benincasa cerifera Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 244000025797 Castanea pumila Species 0.000 description 1
- 235000007763 Castanea pumila Nutrition 0.000 description 1
- 244000026572 Castanopsis indica Species 0.000 description 1
- 235000007722 Castanopsis indica Nutrition 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000219428 Fagaceae Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000218791 Ginkgoaceae Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 201000004239 Secondary hypertension Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- FFMONIZWAPKQCW-CGHBYZBKSA-N angiotensinamide Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1[N]C=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 FFMONIZWAPKQCW-CGHBYZBKSA-N 0.000 description 1
- 229960001119 angiotensinamide Drugs 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 229940110331 bextra Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 229940124567 diuretic antihypertensive agent Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- GLBJJMFZWDBELO-UHFFFAOYSA-N pimobendane Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C=3C(CC(=O)NN=3)C)C=C2N1 GLBJJMFZWDBELO-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- LNPDTQAFDNKSHK-UHFFFAOYSA-N valdecoxib Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C1=CC=C(S(N)(=O)=O)C=C1 LNPDTQAFDNKSHK-UHFFFAOYSA-N 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了降血压茶饮,它按以下重量份混合:银杏叶20~100份、夏枯草20~100份、苦槠树皮20~100份、生首乌30~60份、冬瓜皮20~40份、水300~1500份;并放入容器中浸泡30~60分钟;再容器内加入鸡蛋或鸭蛋,加火将浸泡后的混合物进行熬制搅拌2~3次;e、熬制完成后,过滤出40~50%,即成第一熬制液;f、再进行d步骤熬制剩余混合物,过滤出30~40%,即成第二熬制液;g、将第一熬制液和第二熬制液混合,过滤、澄清、调配、杀菌、灌装后即成降血压茶饮。本发明主治高血压、高血脂,兼养肝肾,具有治疗和保健的双重功效;原材料取材容易,易于批量生产,适用于所有人群,便于推广。
Description
技术领域
本发明涉及一种中药保健食品,尤其是涉及一种中草药复配的降血压茶饮。
背景技术
高血压是持续血压过高的疾病,会引起中风、心脏病、血管瘤、肾衰竭等疾病,高血压是一种以动脉压升高为特征,可伴有心脏、血管、脑和肾脏等器官功能性或器质性改变的全身性疾病,它有原发性高血压(遗传性高血压)和继发性高血压(症状性高血压,由其他疾病引发)之分。西医不能治疗高血压,只能控制血压,六七类降压药主要通过两种途经控制血压,一是减少血容量,二是扩张血管,从内外两个方面减少血液对血管壁的侧压力,达到降血压的目的。西药降血压的药物包括利尿降压药、β受体阻滞药、钙拮抗药、血管紧张素转换酶抑制药、血管紧张素胺受体拮抗药、α受体阻滞药、直接血管扩张药等等,这些药物存在以下弊端:1、使血管脆化,促使脑溢血爆发;2、治标不治本,加速血管淤阻;3、扩张血管药,老化副作用严重;4、长期服用西药,其需要经过肝肾代谢,严重伤害肝肾,产生各种病变,而且西药治疗高血压需要很严格的饮食禁忌。现有市场上也有部分辅助治疗降血压的茶饮在普通茶叶中加入中草药的,但是普通茶叶中含有大量鞣酸,很容易与生物碱发生不溶性沉淀,而很多中药的有效成分都是生物碱,其他像元胡、大蓟、小蓟、川牛膝、曼陀罗等有效成分也主要是生物碱,因此在普通茶叶中加入中草药治疗高血压因为存在解药性,所以效果不是很好。
发明内容
针对上述现有技术中用西药降血压所存在的问题,本发明提供了一种不仅既能迅速降血压、软化血管、无饮食禁忌,又防止复发、治疗周期短、保护人体肝肾的降血压茶饮。
本发明要解决的技术问题所采取的技术方案是:所述降血压茶饮包括以下组分原料:鸡蛋或鸭蛋、银杏叶、夏枯草、苦槠树皮、生首乌、冬瓜皮和水,并用下述方法制备而成:a、将下述组份原料按重量份混合:银杏叶20~100份、夏枯草20~100份、苦槠树皮20~100份、生首乌30~60份、冬瓜皮20~40份、水300~1500份;b、将上述组份原料的混合料放入容器中浸泡30~60分钟;c、在b步骤的容器内加入鸡蛋或鸭蛋,鸡蛋或鸭蛋与a步骤的混合料的比例按照1个︰1000g加入,d、加火将浸泡后的混合料进行熬制,先用武火熬制40~60分钟,武火煮沸后再用文火熬制30~40分钟,期间搅拌2~3次;e、熬制完成后,过滤出40~50%,即成第一熬制液;f、再进行d步骤熬制剩余混合料,过滤出30~40%,即成第二熬制液;g、将第一熬制液和第二熬制液混合,过滤、澄清、调配、杀菌、灌装后即成降血压茶饮。
进一步地,所述a步骤中:将上述各组份原料按以下重量份混合:银杏叶30~60份、夏枯草40~80份、苦槠树皮30~50份、生首乌40~50份、冬瓜皮25~35份、水500~1000份。
进一步地,所述组份原料还包括草决明15~30份、生山楂15~25份。
上述组分原料中,银杏叶(又称白果树叶),为银杏科植物银杏GinkgobilobaL.的干燥叶,其中以黄酮为主的有效成分,具有保护毛细血管通透性、扩张冠状动脉、恢复动脉血管弹性、降低血清胆固醇、增加冠状动脉血流量、改善心脑血管循环、解除平滑肌痉挛、松弛支气管和抑菌、营养脑细胞及其它器官的作用,而且还有使动脉、末梢血管、毛细血管中的血质与胆固醇维持正常水平的功效。用于瘀血阻络,胸痹心痛,中风偏瘫,肺虚咳喘,高脂血症。
夏枯草(又称为矮子驮伞、铁色草、棒槌草、大头花),几乎全国可见,主产于华东华南地区,性苦辛而寒,入肝、胆经,能清肝明目,消肿散结,嫩茎叶中含有蛋白质、脂肪、碳水化合物、胡萝卜素、维生素B2、尼克酸和维生素C等成分。此外,还含有皂甙、芦丁、夏枯草甙、金丝桃甙及挥发油等。(提起中药降压,大多数人的第一反应就是罗布麻,市面上也有很多以罗布麻为主的降压复合制剂,然而,罗布麻有小毒,不宜久服或大剂量服用)。
苦槠树,别名苦槠栲、槠栗、槠树等,属壳斗科,是常绿乔木,它是亚热带常绿阔叶林的主要种群之一,江西地区分布广泛,其果实及树皮有益气,充饥,明目,壮筋骨,助阳气,补虚劳,健腰膝,盖颜色等效用。
鸡蛋或鸭蛋,富含锌、铁、钙、铜等元素,用卵黄制取的卵磷脂可促进Ch(胆固醇)和蛋白质结合而降低血浆Ch。卵磷脂是构成HDL(高密度脂蛋白)的基本成分,卵磷脂对于促进肝细胞再生,降低肝内Ch,维持正常血液循环及造血功能具有重要作用,同时,又可维持胆固醇脂酶活性,影响体内脂肪的运输,而防止其沉着,有一定的抗As(动脉硬化)、抗脂肪肝和预防脑血管障碍的作用。
草决明,豆科一年生草本植物决明或小决明的干燥成熟种子,味苦、甘而性凉,具有清肝火、祛风湿、益肾明目等功能。决明子药性寒凉,有泄泻和降血压的作用。
生山楂,主要含有黄酮类、低聚黄烷类、有机酸类、微量元素,另外还有含有三萜类、甾体类和有机胺类等成分,有扩张外周血管并具有持久的降压作用,尤其对冷血动物的降压作用持续时间最长。
生首乌,又名何首乌,其性微温,味苦、甘、涩,何首乌功效作用的物质基础主要为磷脂、蒽醌类、葡萄糖苷类等成分,可提高机体免疫功能,降血脂,抗动脉粥样硬化,保肝,延缓衰老,影响内分泌功能,润肠通便等作用。
冬瓜皮,为葫芦科植物冬瓜Benincasahispida(Thunb.)Cogn.的干燥外层果皮,味甘,性凉,能降血压,利尿消肿。
本发明的有益效果:相比现有技术,1、所用组分均为中草药常见药,无任何副作用,见效时间短且不需要长期服用,血压控制后不易复发,不需严格戒口;2、主治高血压、高血脂,兼养肝肾,具有治疗和保健的双重功效;3、所述原材料取材容易,易于批量生产,适用于所有人群,便于推广。
具体实施方式
为了使本领域技术人员更好地理解本发明的技术方案,下面结合具体实施例来进一步详细描述本发明。
实施例1
降血压茶饮,包括以下组份原料混合:鸡蛋、银杏叶、夏枯草、苦槠树皮、水。其制备方法包括:a、将上述组份原料按以下重量份混合(每份按1g计算):银杏叶20份、夏枯草20份、苦槠树皮20份、水300份;b、将上述组份原料的混合料放入容器中浸泡30~60分钟;c、在b步骤的容器内加入一个鸡蛋;d、加火将浸泡后的混合料进行熬制,先用武火(大火、或使水面四处沸腾欲溢的火)熬制40~60分钟,武火煮沸后再用文火(小火、或使水微微沸腾的火)熬制30~40分钟,期间搅拌2~3次;e、熬制完成后,过滤出40~50%,即成第一熬制液;f、再进行d步骤熬制剩余混合料,过滤出30~40%,即成第二熬制液;g、将第一熬制液和第二熬制液混合,过滤、澄清、调配、杀菌、灌装后即成降血压茶饮。
实施例2
降血压茶饮,包括以下组份原料:鸭蛋、银杏叶、夏枯草、苦槠树皮、水、生首乌、冬瓜皮;
其制备方法包括:a、将上述组份原料按以下重量份混合(每份按1g计算):银杏叶100份、夏枯草100份、苦槠树皮100份、生首乌40份、冬瓜皮25份、水1500份;b、将上述组份原料的混合料放入容器中浸泡30~60分钟;c、在b步骤的容器内加入2个鸭蛋(其余步骤同实施例1)。
其中加入生首乌的作用是降血脂、防止动脉硬化、保肝,加入冬瓜皮的作用是利尿消肿,降血压,有此类症状可酌情加入。
实施例3
降血压茶饮,包括以下组份原料:鸭蛋、银杏叶、夏枯草、苦槠树皮、水、生首乌、冬瓜皮;
其制备方法包括:a、将上述组份原料按以下重量份混合(每份按1g计算):银杏叶30份、夏枯草40份、苦槠树皮30份、生首乌60份、冬瓜皮40份、水500份;b、将上述组份原料的混合料放入容器中浸泡30~60分钟;c、在b步骤的容器内加入一个鸭蛋(其余步骤同实施例1)。
实施例4
降血压茶饮,包括以下组份原料:鸡蛋、银杏叶、夏枯草、苦槠树皮、水、草决明、生山楂、生首乌、冬瓜皮;
其制备方法包括:a、将上述组份原料按以下重量份混合(每份按1g计算):银杏叶60份、夏枯草80份、苦槠树皮50份、草决明15份、生山楂15份、生首乌30份、冬瓜皮20份、水1000份;b、将上述组份原料的混合料放入容器中浸泡30~60分钟;c、在b步骤的容器内加入一个鸡蛋(其余步骤同实施例1)。
其中加入草决明的作用是清肝火、益肾、明目,加入生山楂的作用是提高免疫能力、补气养生、活化血管,有此类症状可酌情加入。
治疗例1
张远均,男,52岁,工厂工人,家住萍乡市安源区八一街,患者自己介绍全身乏力、肝区有疼痛,间歇性头眩目胀。慢性乙肝史8年,高血压史多年,长期服用西药降压药,肝功能反复波动,曾在多家医院治疗,病情未见改善,经人介绍来我处就治,平时血压160/100mmHg持高不下,B超提示肝硬化,口服降压药疗效差,视其舌质紫苔发白,诊断为肝硬化、高血压,治法以益气健脾、滋补肝肾、活血软坚为主,告知煎药方法、服药时间一年2-3次,一次500ml,服完停药观察8天每天检测血压,第二年回诊,血压120/80mmHg,肝功能正常平稳无反复。
治疗例2
高淑英,女,56岁,煤矿退休人员,家住萍乡市安源区高坑镇,患高血压连续六年,头晕严重,大便不畅,身体微胖,血压检测最高150/96mmHg,天天吃一次西药降压药,诊断为肾虚、高血压,高血脂,治法以滋补肝肾、活血通便、降低血脂为主,告知停用西药,并将煎药方法告之、服药时间一年2次,一次500ml,服完停药,观察一个星期每天检测血压,当年即回诊,血压125/88mmHg,自述大便通畅,无头晕目眩症状。
治疗例3
李远航,男,34岁,货运司机,家住萍乡市上栗县金山镇,有家族高血压遗传史,询问后得知其平时因为工作需要长期开车,回家疲劳也很少运动,饮食也多以高胆固醇食物为主,又好烟酒,自述偶尔头晕、头痛,记忆力减退,并不知道自己得了什么病,根据多年行医经验诊断为高血压、高血脂,经血压检测为152/100mmHg,目前青少年得高血压的人逐渐增多,当告之病情后都不相信,患者可能发现比较早加之增加运动量,将煎药方法告之,开车时瓶装携带,服药两次500ml后,一个星期后检测血压,血压120/87mmHg,自述无头晕、头痛症状,之后也未发现复发症状。
以上实施方式仅用以说明本发明的技术方案而非限制,尽管参照具体实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的精神和范围,其均应涵盖在本发明的权利要求保护的范围中。
Claims (3)
1.降血压茶饮,其特征在于:它包括以下组份原料:鸡蛋或鸭蛋、银杏叶、夏枯草、苦槠树皮、生首乌、冬瓜皮和水,并按下述方法制备而成:a、将下述组分按重量份混合:银杏叶20~100份、夏枯草20~100份、苦槠树皮20~100份、生首乌30~60份、冬瓜皮20~40份、水300~1500份;b、将上述组份原料的混合料放入容器中浸泡30~60分钟;c、在b步骤的容器内加入鸡蛋或鸭蛋,鸡蛋或鸭蛋与a步骤的混合料的比例按照1个︰1000g加入,d、加火将浸泡后的混合物进行熬制,先用武火熬制40~60分钟,武火煮沸后再用文火熬制30~40分钟,期间搅拌2~3次;e、熬制完成后,过滤出40~50%,即成第一熬制液;f、再进行d步骤熬制剩余混合料,过滤出30~40%,即成第二熬制液;g、将第一熬制液和第二熬制液混合,过滤、澄清、调配、杀菌、灌装后即成降血压茶饮。
2.根据权利要求1所述的降血压茶饮,其特征在于:在a步骤中:所述组份原料按下述重量份混合:银杏叶30~60份、夏枯草40~80份、苦槠树皮30~50份、生首乌40~50份、冬瓜皮25~35份、水500~1000份。
3.根据权利要求1或2所述的降血压茶饮,其特征在于:所述组份原料中还包括草决明15~30份、生山楂15~25份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610089076.5A CN105521036A (zh) | 2016-02-18 | 2016-02-18 | 降血压茶饮 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610089076.5A CN105521036A (zh) | 2016-02-18 | 2016-02-18 | 降血压茶饮 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105521036A true CN105521036A (zh) | 2016-04-27 |
Family
ID=55763782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610089076.5A Pending CN105521036A (zh) | 2016-02-18 | 2016-02-18 | 降血压茶饮 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105521036A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107549412A (zh) * | 2017-10-26 | 2018-01-09 | 浦北县德海种养农产品加工专业合作社 | 红树林果降压茶及其制备方法 |
CN107582881A (zh) * | 2017-08-23 | 2018-01-16 | 陈居旭 | 一种降脂降压和排毒减肥的中药组合物 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1421228A (zh) * | 2002-12-03 | 2003-06-04 | 郭志忠 | 一种降血压、降血脂的茶、药茶和含片及其制备方法 |
CN101129515A (zh) * | 2007-09-16 | 2008-02-27 | 牛兴民 | 一种降血压降血脂茶的制备方法 |
CN101147527A (zh) * | 2007-11-12 | 2008-03-26 | 陈二更 | 一种能使鸭蛋具有软化血管和降压作用的饲料及制备方法 |
CN101214296A (zh) * | 2008-01-04 | 2008-07-09 | 山西省晋城市医药科学研究所 | 一种治疗高血压的药物及其制备方法 |
CN101991787A (zh) * | 2009-08-26 | 2011-03-30 | 马黎晓 | 一种具有润肺、降血压功效的中药保健茶 |
CN102461689A (zh) * | 2010-11-19 | 2012-05-23 | 杨海军 | 一种降压保健茶 |
CN102920807A (zh) * | 2012-11-26 | 2013-02-13 | 龚定军 | 一种降血压的药茶 |
-
2016
- 2016-02-18 CN CN201610089076.5A patent/CN105521036A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1421228A (zh) * | 2002-12-03 | 2003-06-04 | 郭志忠 | 一种降血压、降血脂的茶、药茶和含片及其制备方法 |
CN101129515A (zh) * | 2007-09-16 | 2008-02-27 | 牛兴民 | 一种降血压降血脂茶的制备方法 |
CN101147527A (zh) * | 2007-11-12 | 2008-03-26 | 陈二更 | 一种能使鸭蛋具有软化血管和降压作用的饲料及制备方法 |
CN101214296A (zh) * | 2008-01-04 | 2008-07-09 | 山西省晋城市医药科学研究所 | 一种治疗高血压的药物及其制备方法 |
CN101991787A (zh) * | 2009-08-26 | 2011-03-30 | 马黎晓 | 一种具有润肺、降血压功效的中药保健茶 |
CN102461689A (zh) * | 2010-11-19 | 2012-05-23 | 杨海军 | 一种降压保健茶 |
CN102920807A (zh) * | 2012-11-26 | 2013-02-13 | 龚定军 | 一种降血压的药茶 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107582881A (zh) * | 2017-08-23 | 2018-01-16 | 陈居旭 | 一种降脂降压和排毒减肥的中药组合物 |
CN107549412A (zh) * | 2017-10-26 | 2018-01-09 | 浦北县德海种养农产品加工专业合作社 | 红树林果降压茶及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102824393B (zh) | 用于祛风止痛散寒除湿的药物组合物及其制备方法 | |
CN103860903B (zh) | 一种降血压、降血糖、降血脂的药酒 | |
CN103518799B (zh) | 一种芹菜蜂蜜保健蛋糕及其制作方法 | |
CN104587311B (zh) | 健脾去湿的中药提取物及其制备方法、应用和健脾去湿膏 | |
CN106214989A (zh) | 一种抗衰老、改善记忆力的鹿血保健药酒及其制备方法 | |
CN105250913B (zh) | 一种治疗蛋鸡脂肪肝综合症的药物组合物 | |
CN101755970A (zh) | 一种降血压保健茶 | |
CN103990079A (zh) | 用于治疗气滞血瘀型腰肌劳损的药物组合物及其制备方法 | |
CN105521036A (zh) | 降血压茶饮 | |
CN104293627A (zh) | 补精益气养生中药酒及制备方法 | |
CN104474079A (zh) | 活血化瘀养生中药酒及制备方法 | |
CN103960415A (zh) | 一种减肥保健凉茶及其制备方法 | |
CN103725587A (zh) | 黄精山楂醋及其生产方法 | |
CN103830434A (zh) | 治眩晕药酒 | |
CN103355660A (zh) | 一种改善骨质的能增强骨密度的保健食品及其制备方法 | |
CN107158333A (zh) | 一种可有效治疗荨麻疹的中药组合物 | |
KR101381277B1 (ko) | 홍삼을 함유하는 고장초 겔 | |
CN102552410B (zh) | 一种治疗高血压疾病药物的制备方法 | |
CN102205010A (zh) | 一种具有辅助降血脂功能的药物组合物 | |
CN102823405B (zh) | 一种治疗高血压人参的培育方法 | |
CN106070912A (zh) | 一种三叶降压茶凉茶饮料及其制备方法 | |
CN105288118A (zh) | 主治尿毒症的中药组合物及制法 | |
CN104357290A (zh) | 补益延龄养生中药酒及制备方法 | |
CN104436126A (zh) | 一种治疗班替氏综合征的内服药物及其制备方法 | |
CN104189757A (zh) | 治疗酒精肝的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160427 |
|
RJ01 | Rejection of invention patent application after publication |